Evidence map›Paper›PMID 22541939›Full record

ArticleArthritis research & therapy2012

Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe: a case-control study.

Elisa Alonso-Perez, Marian Suarez-Gestal, Manuel Calaza, Gian Domenico Sebastiani, Rudolf Pullmann, Chryssa Papasteriades, Attila Kovacs, Fotini N Skopouli, Marc Bijl, Ana Suarez and 13 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Arthritis research & therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 16 institutions in 8 countries.

Elisa Alonso-PerezLaboratorio de Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria - Hospital Clinico Universitario de Santiago, Choupana s/n, Santiago de Compostela 15706, Spain.
Marian Suarez-Gestal
Manuel Calaza
Gian Domenico Sebastiani
Rudolf Pullmann
Chryssa Papasteriades
Attila Kovacs
Fotini N Skopouli
Marc Bijl
Ana Suarez
Maurizio Marchini
Sergio Migliaresi
Patricia Carreira
Josep Ordi-Ros
Torsten Witte
Sarka Ruzickova
Maria Jose Santos
Nadia Barizzone
Francisco J Blanco
Bernard R Lauwerys
Juan J Gomez-Reino
Antonio Gonzalez
European Consortium of SLE DNA Collections
Instituto de Investigación Sanitaria de Santiago · ESAzienda Ospedaliera San Camillo-Forlanini · ITCliniques Universitaires Saint-Luc · BECzech Academy of Sciences, Institute of Biotechnology · CZEvangelismos Hospital · GRHospital Garcia de Orta · PTInstituto de Investigación Biomédica de A Coruña · ESMartini Ziekenhuis · NLMedizinische Hochschule Hannover · DEResearch Institute Hospital 12 de Octubre · ESUniversidad de Oviedo · ESUniversidade de Santiago de Compostela · ESUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Milan · ITUniversity of Naples Federico II · ITVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe aimed to investigate whether the effect size of the systemic lupus erythematosus (SLE) risk alleles varies across European subpopulations.

methodsEuropean SLE patients (n = 1,742) and ethnically matched healthy controls (n = 2,101) were recruited at 17 centres from 10 different countries. Only individuals with self-reported ancestry from the country of origin were included. In addition, participants were genotyped for top ancestry informative markers and for 25 SLE associated SNPs. The results were used to compare effect sizes between the Central Eureopan and Southern European subgroups.

resultsTwenty of the 25 SNPs showed independent association with SLE, These SNPs showed a significant bias to larger effect sizes in the Southern subgroup, with 15/20 showing this trend (P = 0.019) and a larger mean odds ratio of the 20 SNPs (1.46 vs. 1.34, P = 0.02) as well as a larger difference in the number of risk alleles (2.06 vs. 1.63, P = 0.027) between SLE patients and controls than for Central Europeans. This bias was reflected in a very significant difference in the cumulative genetic risk score (4.31 vs. 3.48, P = 1.8 × 10-32). Effect size bias was accompanied by a lower number of SLE risk alleles in the Southern subjects, both patients and controls, the difference being more marked between the controls (P = 1.1 × 10-8) than between the Southern and Central European patients (P = 0.016). Seven of these SNPs showed significant allele frequency clines.

conclusionOur findings showed a bias to larger effect sizes of SLE loci in the Southern Europeans relative to the Central Europeans together with clines of SLE risk allele frequencies. These results indicate the need to study risk allele clines and the implications of the polygenic model of inheritance in SLE.

Indexed as

AllelesBiasCase-Control StudiesEuropeFemaleGenetic LociGenetic Predisposition to DiseaseHumansLupus Erythematosus, SystemicMalePolymorphism, Single Nucleotide

Identifiers

PMID22541939
PMCPMC3446468
OpenAlexW2159466485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.